Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

Performance of COCH after de-SPAC sixty day “washout” period among leaders in peer group and Envoy Medical bullish on its long-term strategy

WHITE BEAR LAKE, Minnesota , Oct. 01, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today commemorates its one-year anniversary trading as a public company. On September 29, 2023, the formerly private Envoy Medical merged with Anzu Special Purpose Acquisition Corp I, creating the now publicly traded Envoy Medical. COCH began trading on the Nasdaq Capital Market on October 2, 2023.